The Case That Psychedelics Sometimes Make Thinking Less Flexible
Cognitive flexibility is one of the most cited reasons psychedelics are supposed to work. The drug loosens rigid thinking, the argument goes, and the patient can revise beliefs that were stuck. A review in Neuroscience & Biobehavioral Reviews says the evidence does not actually support that as a reliable effect. Sometimes flexibility gets worse. The review is indexed on PubMed.
Screening and follow up are the two places a practice absorbs this kind of risk. HealingMaps’ GPO, the first built for the ketamine industry, gets member clinics 40 percent or more off medical supplies, 15 to 20 percent off malpractice and liability premiums, discounted LegitScript certification, and 20 to 30 percent off HIPAA compliant payment processing. Joining is free with no obligation. See what your clinic qualifies for →
| Key Takeaway | Detail |
|---|---|
| The paper | A review and proposed model from the McGill Center at UT Austin Dell Medical School |
| What it is not | New data. The authors synthesize existing findings and offer a hypothesis to explain them |
| The core claim | Effects on cognitive flexibility are mixed, and in several studies flexibility was impaired |
| The proposed mechanism | Acute dosing favors learning from reward, which can lock in a belief. Correction comes later |
| Why it matters clinically | It offers an account of why session insights are held so firmly |
| Status | A testable framework, not a settled finding |
What the Paper Actually Argues
The authors reviewed studies measuring two standard tests of flexibility. Reversal learning asks whether a person can update when a rule flips. Set-shifting asks whether they can move attention to a new rule.
Results across those studies did not point one direction. Some showed improvement. Some showed no effect. Several showed impairment.
The team did not average that into a null result. They proposed a model that could produce all three outcomes, depending on when you measure.
The Acute Window May Work Against Flexibility
Their proposal turns on how the brain learns from two different signals. One is reward received. The other is reward expected but withheld.
During the acute drug experience, they argue, learning from reward receipt is amplified. Something that feels meaningful gets encoded strongly and becomes difficult to override.
That is perseveration, not flexibility. It is the opposite of what the standard account predicts.
Correction Arrives Afterward
The second half of the model is what happens once the drug wears off. Learning from reward omission, which is the signal that says an expectation was wrong, appears to strengthen post-acutely.
That is the capacity to revise. On this account it does not peak during the session. It arrives in the days after.
The authors also split the receptor contributions. Reward receipt learning is associated with 5-HT2C activity, reward omission learning more with 5-HT2A and 5-HT1A. That part is early, and best left to researchers for now.
It Explains the Patient Who Will Not Budge
The most useful line in the paper is an aside. The model accounts for why insights reached during a psychedelic session may be held so strongly.
Most clinicians have met that patient. They leave with a conviction that feels revelatory and resists examination, sometimes for weeks.
If the acute state genuinely favors encoding over updating, that stubbornness is not a personality trait. It is a predictable feature of the window the insight formed in. Belief change after psychedelics has already proven more complicated than early reports suggested.
The Timing Argument for Integration
This is where the model earns attention from operators. If revision capacity is post-acute, then integration is not a nice addition to the session. It is the part of the protocol where the correction actually happens.
That runs into a trend we covered this week. As psychedelic care gets leaner, integration work moves home. Thinning out the days after a session may remove the window where a bad conclusion gets revisited.
The authors go further, writing that the framework informs strategies to minimize the formation of maladaptive beliefs. That is a practice concern stated in a mechanisms paper.
How Much Weight It Can Carry
Not much yet, and the authors are clear about that. They propose and hypothesize. They do not report a result.
The value is that it is falsifiable. It predicts flexibility should look worse during dosing and better afterward, which a study can be built to check.
It also arrives with no commercial interest attached. This is an academic center with no industry sponsor, which is not the norm in this literature.
The Practical Read
Nothing here changes a protocol tomorrow. It is a model awaiting a test.
What it does is complicate a claim the field repeats casually. Psychedelics are not reliably flexibility enhancing, and the session itself may be the least flexible moment. We have covered related ground in why some psychedelic experiences turn frightening.
The full review is available on PubMed.
This article is for informational purposes and is not medical advice. It describes a proposed research framework, not an established clinical finding.
